DEA Extends Telemedicine Buprenorphine Rules Through 2026
A final rule now permanently allows buprenorphine via telehealth for up to 6 months without an in-person visit.
Body: [News-style article: what the rule changes, what the 6-month window means in practice, why the field had been bracing for a cliff, what clinicians and patients should know, caveats on state-by-state variation, how it affects telehealth-first programs like Bicycle Health and Ophelia. 800 words.]
Sources Cited
- 01.A
Filed Under
DEAMAT — BuprenorphineFederalPolicy
Keep up with the reporting.
One email each morning with the stories that put days like this in context.
Continue reading
More from this section
The Medicaid Work-Requirement Rule Takes Effect Today. Its Recovery Exemption Has an Expiration Date Built In.
CMS's new Medicaid work-requirement rule is effective today. People in active SUD treatment are exempt — but the exemption disappears after five years in recovery, right when documentation habits have gone slack.
Policy & FundingDEA Wants to Schedule Concentrated 7-OH Kratom Like Heroin. The Comment Window Closes Today.
HHS's public comment period on DEA's plan to temporarily Schedule I concentrated 7-OH kratom compounds closes today. The rule is narrower than the headlines — here's exactly what it does and doesn't touch.
Policy & FundingThe Cannabis Rescheduling Hearing Ended. Only One Side Got to Argue.
DEA's rescheduling hearing on moving marijuana to Schedule III concluded July 15, 2026 without a promised livestream; only formal opponents were credentialed as hearing parties. Post-hearing briefs are due August 17.